Anorexia Tied to Quadrupled Risk of Early Death in Both Men, Women
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
FRIDAY, June 14, 2024 -- Early mortality in people with anorexia nervosa (AN) is high, particularly among those with a psychiatric comorbidity, according to a study published online June 12 in the International Journal of Eating Disorders.
Mette Søeby, M.D., from Aarhus University Hospital in Denmark, and colleagues investigated overall and cause-specific mortality in individuals with AN from 1977 to 2018. Analysis included 14,774 patients with AN followed for a median 9.1 years and matched (1:10) individuals from the general population.
The researchers found that in patients with AN, the weighted average risk for all-cause mortality was more than quadrupled (adjusted hazard ratio, 4.5). At the index AN date, psychiatric comorbidity was present in 47 percent of patients, which was associated with a 1.9-fold increase in 10-year mortality versus patients without comorbidity. When the psychiatric comorbidity was diagnosed at age 6 to 25 years, all-cause mortality risk was increased fourfold. There were no sex differences for mortality risk. Suicide was the cause of 13.9 percent of all deaths in patients with AN (subdistribution hazard ratio, 10.7). Death from natural causes remained increased with AN (subdistribution hazard ratio, 3.8).
"These findings stress the importance of detection and treatment of psychiatric comorbidities alongside the eating disorder to prevent fatal outcome," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-06-15 01:15
Read more
- Duodenal ReCET Plus Semaglutide Can Prevent Need for Insulin in T2DM
- Palleon Pharmaceuticals Presents Results from the Phase 1/2 GLIMMER-01 Trial of E-602 in Combination with Cemiplimab in Patients with Solid Tumors at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
- FDA Approves Itovebi for Locally Advanced, Metastatic Breast Cancer
- FDA Approves Vyloy for Advanced Gastric or Gastroesophageal Junction Cancer
- AI Might Help Pick Up Heart Trouble in Dogs
- Liquor, Wine, Beer: Which Comes With the Worst Lifestyle?
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions